156 related articles for article (PubMed ID: 3918914)
41. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
[TBL] [Abstract][Full Text] [Related]
42. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
Mueller C; Knoflach P; Zielinski CC
Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
[TBL] [Abstract][Full Text] [Related]
43. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
Yacyshyn BR; Lazarovits A; Tsai V; Matejko K
Gastroenterology; 1994 Nov; 107(5):1364-71. PubMed ID: 7523224
[TBL] [Abstract][Full Text] [Related]
44. Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients.
James SP; Fiocchi C; Graeff AS; Strober W
Gastroenterology; 1986 Dec; 91(6):1483-9. PubMed ID: 2945749
[TBL] [Abstract][Full Text] [Related]
45. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability.
Yacyshyn BR; Meddings JB
Gastroenterology; 1995 Jan; 108(1):132-7. PubMed ID: 7528696
[TBL] [Abstract][Full Text] [Related]
46. Enhanced CD3 monoclonal antibody induced proliferation of colonic mucosal T lymphocytes in Crohn's disease patients free of corticosteroid or immunosuppressor treatment.
Jacquot S; Modigliani R; Kuzniak I; Boumsell L; Bensussan A
Clin Immunol Immunopathol; 1996 Apr; 79(1):20-4. PubMed ID: 8612347
[TBL] [Abstract][Full Text] [Related]
47. MHC class II gene products specific autoreactive T cell clones provide inducer as well as amplifier function for B cell Ig production.
Bensussan A; Milanese C; Meuer SC; Reinherz EL
Behring Inst Mitt; 1985 Aug; (77):93-104. PubMed ID: 2417587
[TBL] [Abstract][Full Text] [Related]
48. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
49. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR.
Gonwa TA; Picker LJ; Raff HV; Goyert SM; Silver J; Stobo JD
J Immunol; 1983 Feb; 130(2):706-11. PubMed ID: 6184401
[TBL] [Abstract][Full Text] [Related]
50. HLA antigens in inflammatory bowel disease.
Smolen JS; Gangl A; Polterauer P; Menzel EJ; Mayr WR
Gastroenterology; 1982 Jan; 82(1):34-8. PubMed ID: 6796456
[TBL] [Abstract][Full Text] [Related]
51. [Characteristics of HLA II antigen expression in the rectal mucosa of children suffering form ulcerative colitis and Crohn disease].
Hacsek G; Arató A; Savilahti E; Pászti I
Orv Hetil; 1995 Oct; 136(42):2279-82. PubMed ID: 7478471
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of T cell differentiation antigens and major histocompatibility antigens on activated T cells during the cell cycle.
Matsui Y; Shapiro HM; Sheehy MJ; Christenson L; Staunton DE; Eynon EE; Yunis EJ
Eur J Immunol; 1986 Mar; 16(3):248-51. PubMed ID: 3082649
[TBL] [Abstract][Full Text] [Related]
53. Regulation of the immune response in Plasmodium falciparum malaria. I. Non-specific proliferative responses in vitro and characterization of lymphocytes.
Troye-Blomberg M; Sjöholm PE; Perlmann H; Patarroyo ME; Perlmann P
Clin Exp Immunol; 1983 Aug; 53(2):335-44. PubMed ID: 6349879
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical characterisation of macrophages in human liver and gastrointestinal tract: expression of CD4, HLA-DR, OKM1, and the mature macrophage marker 25F9 in normal and diseased tissue.
Hume DA; Allan W; Hogan PG; Doe WF
J Leukoc Biol; 1987 Nov; 42(5):474-84. PubMed ID: 3500252
[TBL] [Abstract][Full Text] [Related]
55. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
[TBL] [Abstract][Full Text] [Related]
56. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
Morton BA; Ramey WG; Paderon H; Miller RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
[TBL] [Abstract][Full Text] [Related]
57. Immune status in healthy relatives of patients with familial Crohn's disease.
Van Gossum A; Dupont E; Schandene L; Cremer M; Wybran J
Dig Dis Sci; 1988 Aug; 33(8):945-50. PubMed ID: 2968901
[TBL] [Abstract][Full Text] [Related]
58. Differentiation antigens in acute leukaemia.
Reen DJ
Biochem Soc Trans; 1985 Apr; 13(2):420-2. PubMed ID: 3926556
[No Abstract] [Full Text] [Related]
59. Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease.
Gardiner KR; Crockard AD; Halliday MI; Rowlands BJ
Gut; 1994 Apr; 35(4):511-6. PubMed ID: 8174990
[TBL] [Abstract][Full Text] [Related]
60. Pathogenic factors in inflammatory bowel disease. 2. Crohn's disease.
Pavli P; Gibson PR
Dig Dis; 1992; 10(2):72-84. PubMed ID: 1591873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
